Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine (Q40379269)

20 September 2017

title

Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine (English)

1 reference

20 September 2017

Deborah J Marshall

1

1 reference

20 September 2017

Kelly A Rudnick

2

1 reference

20 September 2017

Stephen G McCarthy

3

1 reference

20 September 2017

Lani R San Mateo

4

1 reference

20 September 2017

Michael C Harris

5

1 reference

20 September 2017

Christine McCauley

6

1 reference

20 September 2017

Linda A Snyder

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

15 August 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

24

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

244-253

1 reference

DNA vaccines: immunology, application, and optimization*

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Cloning of a new cytokine that induces IFN-gamma production by T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Comparative analysis of effects of cytokine gene adjuvants on DNA vaccination against Mycobacterium tuberculosis heat shock protein 65

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Enhancement of DNA vaccine potency against herpes simplex virus 1 by co-administration of an interleukin-18 expression plasmid as a genetic adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Comparative affects of plasmid-encoded interleukin 12 and interleukin 18 on the protective efficacy of DNA vaccination against Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Characterization of the Murine Antigenic Determinant, Designated L3T4a, Recognized by Monoclonal Antibody GK 1.5: Expression of L3T4a by Functional T Cell Clones Appears to Correlate Primarily with Class II MHC Antigen-Reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

A T cell-independent antitumor response in mice with bone marrow cells retrovirally transduced with an antibody/Fc-gamma chain chimeric receptor gene recognizing a human ovarian cancer antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Lymphokine control of in vivo immunoglobulin isotype selection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Chemoattraction of Human T Cells by IL-18

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Antitumor activity of interleukin-18 on mouse glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.087

10.1016/J.VACCINE.2005.07.087

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference